Unlocking the Potential of GLP-1 Medications for Obesity Management The webinar, led by health and insurance experts from USI and BioCoach, addresses the emerging trend and implications of GLP-1 medications for obesity and diabetes management in the workplace.
The discussion covers the clinical and financial aspects of these medications, including their benefits, side effects, and the critical role of comprehensive support and education for patients.
Special attention is given to the strategic incorporation of these treatments into employer health plans, emphasizing the need for a well-rounded approach to ensure sustainable weight loss and overall health improvement. The webinar features insights from USI team members and Dr. Jamie Seeman, offering perspectives on both the challenges and solutions in integrating GLP-1 medications into employee health benefits.
The focus is on creating a supportive framework that not only helps manage weight and metabolic health but also retains and supports employees through their health journey.
00:00 Welcome and Introduction to the Webinar
00:14 Navigating the New Era of Obesity Medication
00:50 USI's Role and Expertise in Employee Benefits
02:28 The Impact of GLP-1s on Weight Loss and Employer Costs
05:02 BioCoach's Approach to Managing GLP-1 Medication and Obesity
09:53 The Importance of Support and Education in Medication Adherence
23:44 Dr. Jamie Seeman's Clinical Insights on GLP-1s
